Australian Industry Working To Minimize Medicines Shortages
Country Currently Has 44 Medicines In Critical Shortage
Australia’s branded and generic drug industry associations have jointly raised concerns about the impact ongoing shortages could have on the country’s supply of medicines.
You may also be interested in...
The Australian government has committed to cutting co-payments for medicines listed on its pharmaceutical benefits scheme by 30%, a move which has been praised by the country’s Generic and Biosimilar Medicines Association.
Panelists discussed the issues jeopardizing generics security of supply, the potential impact of pricing changes and international best practice at a recent Politico event.
A busy October will include planned biosimilar launches and key appointments for the off-patent sector.